SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Shirky
Lv2
190 积分
2023-01-13 加入
最近求助
最近应助
互助留言
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
23天前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
23天前
已完结
Abstract S1-11: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)
10个月前
已关闭
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer
1年前
已完结
Preclinical Evaluation of Ixabepilone in Combination with VEGF Receptor and PARP Inhibitors in Taxane-Sensitive and Taxane-Resistant MDA-MB-231 Breast Cancer Cells
1年前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
1年前
已完结
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: a systematic review and meta-analysis
1年前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
1年前
已完结
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
1年前
已完结
KEYNOTE-355 — OS benefit now reported
1年前
已完结
The role of alpha oscillations in temporal binding within and across the senses
1年前
已采纳
暂时不需要原文【积分已退回】
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论